Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedro Cahn

Showing results (111-120 of 207) with videos related to

Pageof 21
Sort By:
AIDS (London, England)|February 25, 2011
Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patientsPedro Cahn, Jan Fourie, Beatriz Grinsztejn, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|July 19, 2017
The HIV care cascade in Buenos Aires, Argentina: results in a tertiary referral hospitalCarina Cesar, Gabriela Blugerman, José Antonio Valiente, et al.
Journal of the International AIDS Society|October 15, 2009
Determinants of Treatment Access in a Population-based Cohort of HIV-positive Men and Women Living in ArgentinaCarlos Zala, Clare A Rustad, Keith Chan, et al.
Medscape Journal of Medicine|May 28, 2008
Determinants of treatment access in a population-based cohort of HIV-positive men and women living in ArgentinaCarlos Zala, Clare A Rustad, Keith Chan, et al.
Basic & Clinical Pharmacology & Toxicology|October 4, 2007
Pharmacokinetics of two randomized trials evaluating the safety and efficacy of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir: the MaxCmin1 and 2 trialsUlrik S Justesen, Zoe Fox, Court Pedersen, et al.
Scientific Reports|August 2, 2014
MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitroRita Reynoso, Natalia Laufer, Matthias Hackl, et al.
Plos One|January 20, 2023
Retention among transgender women treated with dolutegravir associated with tenofovir/lamivudine or emtricitabine in Argentina: TransViiV studyClaudia E Frola, Inés Aristegui, María I Figueroa, et al.
International Journal of STD & AIDS|February 3, 2021
Acceptability of dual HIV/syphilis rapid test in community- and home-based testing strategy among transgender women in Buenos Aires, ArgentinaVirginia Zalazar, Claudia E Frola, Ana Gun, et al.
Journal of the International AIDS Society|June 21, 2012
ICOS, SLAM and PD-1 expression and regulation on T lymphocytes reflect the immune dysregulation in patients with HIV-related illness with pulmonary tuberculosisJavier Oscar Jurado, Virginia Pasquinelli, Ivana Belén Alvarez, et al.
AIDS Care|April 28, 2016
Implementation and uptake of the Conexiones y Opciones en la Argentina intervention: feasibility and acceptabilityDeborah L Jones, Mar Lucas, Inés Arístegui, et al.
Pageof 21

Showing results (111-120 of 207) with videos related to

Sort By:
Pageof 21
AIDS (London, England)|February 25, 2011
Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patientsPedro Cahn, Jan Fourie, Beatriz Grinsztejn, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|July 19, 2017
The HIV care cascade in Buenos Aires, Argentina: results in a tertiary referral hospitalCarina Cesar, Gabriela Blugerman, José Antonio Valiente, et al.
Journal of the International AIDS Society|October 15, 2009
Determinants of Treatment Access in a Population-based Cohort of HIV-positive Men and Women Living in ArgentinaCarlos Zala, Clare A Rustad, Keith Chan, et al.
Medscape Journal of Medicine|May 28, 2008
Determinants of treatment access in a population-based cohort of HIV-positive men and women living in ArgentinaCarlos Zala, Clare A Rustad, Keith Chan, et al.
Basic & Clinical Pharmacology & Toxicology|October 4, 2007
Pharmacokinetics of two randomized trials evaluating the safety and efficacy of indinavir, saquinavir and lopinavir in combination with low-dose ritonavir: the MaxCmin1 and 2 trialsUlrik S Justesen, Zoe Fox, Court Pedersen, et al.
Scientific Reports|August 2, 2014
MicroRNAs differentially present in the plasma of HIV elite controllers reduce HIV infection in vitroRita Reynoso, Natalia Laufer, Matthias Hackl, et al.
Plos One|January 20, 2023
Retention among transgender women treated with dolutegravir associated with tenofovir/lamivudine or emtricitabine in Argentina: TransViiV studyClaudia E Frola, Inés Aristegui, María I Figueroa, et al.
International Journal of STD & AIDS|February 3, 2021
Acceptability of dual HIV/syphilis rapid test in community- and home-based testing strategy among transgender women in Buenos Aires, ArgentinaVirginia Zalazar, Claudia E Frola, Ana Gun, et al.
Journal of the International AIDS Society|June 21, 2012
ICOS, SLAM and PD-1 expression and regulation on T lymphocytes reflect the immune dysregulation in patients with HIV-related illness with pulmonary tuberculosisJavier Oscar Jurado, Virginia Pasquinelli, Ivana Belén Alvarez, et al.
AIDS Care|April 28, 2016
Implementation and uptake of the Conexiones y Opciones en la Argentina intervention: feasibility and acceptabilityDeborah L Jones, Mar Lucas, Inés Arístegui, et al.
Pageof 21